Australia markets open in 59 minutes

Aditxt, Inc. (ADTX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.0900+0.0800 (+3.98%)
At close: 04:00PM EDT
2.1100 +0.02 (+0.96%)
After hours: 06:30PM EDT

Aditxt, Inc.

737 North Fifth Street
Suite 200
Richmond, VA 23219
United States
650 870 1200
https://www.aditxt.com

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees47

Key executives

NameTitlePayExercisedYear born
Mr. Amro A. AlbannaCo-Founder, Chairman & CEO472.12kN/A1970
Dr. Shahrokh Shabahang D.D.S., M.S., Ph.D.Co-Founder, Chief Innovation Officer, Secretary & Director323.5kN/A1963
Mr. Thomas J. Farley CPAChief Financial Officer357.89kN/A1973
Ms. Corinne D. Pankovcin CPA, M.B.A.Chief Commercialization Officer366.77kN/A1966
Ms. Rowena AlbannaChief Operating OfficerN/AN/A1966
Ms. Jennifer LeeDirector of Human ResourcesN/AN/AN/A
Dr. Dolly B. Tyan Ph.D.Senior Vice President of Clinical Development – TransplantationN/AN/AN/A
Mr. Ge Chen M.D., M.S.Senior Vice President of Preclinical Research & DiscoveryN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.

Corporate governance

Aditxt, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.